BNP concentration in patients with mitral stenosis. Dependence on selected morphological parameters

Archives of Medical Science

Volumn 2, Issue 3, 2006, Pages 159-163

  Irzmański, Robert ^a   Banach, Maciej ^a   Piechota, Mariusz ^a   Barylski, Marcin ^a   Serwa Stȩpień, Ewa ^a   Cierniewski, Czesław ^a   Jegier, Bogdan ^a   Kowalski, Jan ^a   Pawlicki, Lucjan ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Atrial fibrillation; BNP; Haemodynamic parameters; Mitral stenosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; LUNG ARTERY PRESSURE; MITRAL VALVE; MITRAL VALVE STENOSIS; MORPHOLOGY; RADIOIMMUNOASSAY;

EID: 33750626050     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. st century. Hellenic J Cardiol 2002; 43: 183-8.
2. Egeblad H, Berning J, Saunamaki K, Jacobsen JR, Wennevold A. Assessment of rheumatic mitral valve disease. Value of echocardiography in patients clinically suspected of predominant stenosis. Br Heart J 1983; 49: 38-44.
3. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-22.
4. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-21.
5. Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation 2002; 105: 2328-31.
6. Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41: 2280-7.
7. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63.
8. Latini R, Masson S, de Angelis N, Anand I. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. J Card Fail 2002; 8: 288-99.
9. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105: 2392-7.
10. Maisel AS, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P, et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 2003; 41: 2010-7.
11. Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC Jr, et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation. 2005; 111: 2391-7.
12. Gerber IL, Stewart RAH, French R, Legget ME, Greaves SC, West TM, et al. Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. J Am Coll Cardiol 2003; 92(6): 755-8.
13. Lim P, Monin JL, Monchi M, Garot J, Pasquet A, Hittinger L, et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 2004; 25: 2048-53.
14. Tharaux PL, Dussaule JC, Hubert-Brierre J, Vahanian A, Acar J, Ardaillou R. Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy. Clin Sci (Lond) 1994; 87: 671-7.
15. Nakamura M, Kawata Y, Yoshida H et al. Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis. Am Heart J 1992; 124: 1283-8.
16. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
17. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000; 6: 92-6.